Quintrio
Home

Stock overview

KONINKLIJKE PHILIPS N.V.

PHG

Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound and X-ray equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.

Last trade $29.97
Day change -$0.175 (-0.58%)
Day range $29.75 – $30.17
Volume 678,938
Market cap $29.47B

Open XNYS

Fundamentals

Key company ratios and reported financial statements.

Source: Massive.com

Key ratios

No ratio data was found for PHG.

Financial statements

Income and cash flow amounts are for the period; balance sheets are point-in-time snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are displayed when available.

No quarterly income statement data was found for PHG.

Recent news

Company coverage with links to the original publishers.

Publication times in UTC
Zacks Investment Research

Here's Why You Should Retain PHG Stock in Your Portfolio for Now

Koninklijke Philips reported strong equipment order intake growth of 8% with Diagnosis & Treatment orders surging nearly 20%, and Personal Health sales rising 8%. However, ultrasound manufacturing delays, China's pricing pressure from centralized procurement, and inflation concerns pose significant risks to profitability and growth trajectory. The company maintains a Zacks Rank #3 (Hold) rating.

The Motley Fool

Philips: 3 Key Takeaways for Long-Term Investors

Philips reported 8% equipment order intake growth in Q3 2026, driven by hospitals consolidating vendors and prioritizing clinical value over price. The company is scaling its Enterprise Monitoring as a Service subscription model with revenues nearly doubling year-over-year, while productivity savings of EUR 170 million in Q3 are offsetting inflation pressures. Management remains on track for mid-single-digit comparable sales growth CAGR through 2028 and mid-teen adjusted EBITA margins by 2028.

GlobeNewswire Inc.

Medical Imaging Workstations Market Size, Share, Trends, and Forecast Analysis - Global Forecast to 2036 | AI, Cloud, and Enterprise Imaging Drive 7.3% CAGR and USD 12.55 Billion Opportunity

The global medical imaging workstations market is estimated at USD 6.20 billion in 2026 and projected to reach USD 12.55 billion by 2036, expanding at a CAGR of 7.3%. Growth is driven by rising chronic disease prevalence, digital imaging infrastructure investments, AI integration, and enterprise imaging adoption. Key challenges include high costs, cybersecurity risks, and radiologist shortages, while opportunities exist in cloud-based solutions and emerging markets.

Zacks Investment Research

Philips Launches HyperVue Integrated System to Improve PCI Workflows

Koninklijke Philips announced the U.S. commercial launch of its HyperVue Integrated System, combining advanced coronary imaging (DeepOCT+NIRS) with AI-driven physiology assessment (X1-FFR) in a permanently installed cath lab configuration. The system aims to streamline percutaneous coronary intervention procedures and strengthen Philips' position in the interventional cardiology market, which is projected to grow at 7.3% CAGR through 2033.

GlobeNewswire Inc.

Philips launches HyperVue Integrated System in the U.S., bringing advanced coronary imaging and physiology into the cathlab

Royal Philips announced U.S. commercial availability of the HyperVue Integrated System, a fixed single-room configuration combining DeepOCT+NIRS imaging and X1-FFR physiology assessment for coronary interventions. The system is designed to streamline cathlab workflows by eliminating setup steps and keeping advanced imaging and physiology tools readily available. Philips will showcase this alongside its broader portfolio including IntraSight Plus at TCT 2026.

Dividends

Declared distributions and recorded event dates. Forecasts are not shown.

Updated daily

No declared upcoming dividend found.

Ex-dividendAmount / sharePay dateType
May 13, 2026$0.99Jun 3, 2026recurring
May 13, 2025$0.9327Jun 6, 2025recurring
May 12, 2022$0.781Jun 8, 2022recurring
May 10, 2021$0.8541Jun 9, 2021recurring
May 13, 2019$0.764Jun 13, 2019recurring

Stock splits

Historical share-structure events and their execution dates.

Updated daily
Execution dateSplit ratioEvent type
May 13, 20261.037-for-1stock dividend
May 13, 20251.042-for-1stock dividend
May 9, 20241.034-for-1stock dividend
May 11, 20231.045-for-1stock dividend
May 12, 20221.037-for-1stock dividend
May 10, 20211.019-for-1stock dividend
Jun 30, 20201.02-for-1stock dividend
May 13, 20191.024-for-1stock dividend